Target validation plays a pivotal role in reducing costs in drug development by improving the efficiency and success rate of downstream R&D. EnquBio has assembled a team of Ph.D.-level scientists, each with over a decade of experience, and developed robust, cutting-edge platforms. We deliver comprehensive services to elucidate targets within the context of disease biology, enabling more informed and confident decision-making in drug development.

​

Our services include: